XML 25 R15.htm IDEA: XBRL DOCUMENT v3.26.1
Note 8 - Earnings Per Share
3 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Earnings Per Share [Text Block]

8. Earnings Per Share

 

The Company calculates earnings per share (“EPS”) as required by FASB ASC Topic No. 260, Earnings Per Share. Basic EPS is calculated by dividing the net income attributable to common stockholders by the weighted average number of common shares outstanding for the period, excluding common stock equivalents. Diluted EPS is computed by dividing the net income attributable to common stockholders by the weighted average number of common shares outstanding for the period, plus the weighted average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For periods with a net loss, the dilutive common stock equivalents are excluded from the diluted EPS calculation. For purposes of this calculation, Common Stock subject to repurchase by the Company, options, warrants (other than the Pre-Funded Warrants), and convertible notes are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share when their effect is dilutive.

 

The following table sets forth the details of basic and diluted earnings per share (unaudited, in thousands, except per share amounts):

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

 

 

Net loss

 

$

(3,897

)

 

$

(5,178

)

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

Weighted average shares outstanding – basic

 

 

25,695

 

 

 

18,216

 

Potential common shares – options / warrants (treasury stock method)

 

 

 

 

 

 

Weighted average shares outstanding – diluted

 

 

25,695

 

 

 

18,216

 

Shares excluded (anti-dilutive)

 

 

21,739

 

 

 

8,406

 

 

 

 

 

 

 

 

 

 

Net loss per share – basic and diluted

 

 

 

 

 

 

 

 

Basic

 

$

(0.15

)

 

$

(0.28

)

Diluted

 

$

(0.15

)

 

$

(0.28

)

 

The following weighted average shares were excluded from the computation of diluted net loss per share attributable to common stockholders as the impact of including those shares would be anti-dilutive (unaudited, in thousands):

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Convertible notes as if converted

 

 

1,697

 

 

 

 

Outstanding stock options

 

 

33

 

 

 

24

 

Outstanding warrants

 

 

20,009

 

 

 

8,382

 

Total anti-dilutive shares

 

 

21,739

 

 

 

8,406